Seoul Pharma Co. Ltd (018680) — Cash Flow Reinvestment Rate
Seoul Pharma Co. Ltd (018680) has a Cash Flow Reinvestment Rate of 0.52x as of June 2025, reinvesting ₩1.07 Billion (capex ₩89.75 Million plus investments ₩979.26 Million) from operating cash flow of ₩2.07 Billion. See Seoul Pharma Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seoul Pharma Co. Ltd Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for Seoul Pharma Co. Ltd across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Seoul Pharma Co. Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year capital reinvestment analysis for Seoul Pharma Co. Ltd. See Seoul Pharma Co. Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.47x | ₩7.76 Billion | ₩5.26 Billion | ₩1.89 Billion | ▲ +776.4% |
| 2020 | 0.17x | ₩964.40 Million | ₩5.74 Billion | ₩671.25 Million | ▲ +214.7% |
| 2019 | 0.05x | ₩156.43 Million | ₩2.93 Billion | ₩156.43 Million | ▼ -94.7% |
| 2015 | 1.01x | ₩1.43 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -43.8% |
| 2014 | 1.80x | ₩2.66 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -7.8% |
| 2012 | 1.95x | ₩17.95 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +71.3% |
| 2011 | 1.14x | ₩5.53 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -78.8% |
| 2009 | 5.36x | ₩6.62 Billion | ₩1.23 Billion | ₩6.11 Billion | — |